United States - 65--Compounded Chemotherapy Drugs

Description

Added: Sep 02, 2019 1:36 pm

This is a combined synopsis/solicitation for commercial supplies prepared in accordance with the format in Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26219Q1294.

The Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California 90822 has a requirement to provide hazardous compounded chemotherapy drugs for VA Medical Center Long Beach, Pharmacy Service.

VA LONG BEACH HEALTHCARE SYSTEM:

Delivery Location Pharmacy Service, Bldg. 164

Normal Work Hours 7:00am to 4:00pm, Monday through Saturday

There will be approximately (30) thirty patients on any given day, Monday through Friday for chemotherapy infusion for 23 weeks.  Below is a list of the common chemotherapy drugs will be provided directly to the vendor. Must be able to supply and deliver all hazardous compounded chemotherapy drugs listed below. Orders are based on need for each patient. Please include the temperature logger in shipments to monitor temperature of drugs for quality assurance. Shipping fees must be inclusive (cost per week) within the hazardous compounded chemotherapy drug.

The period of performance is October 1, 2019 to September 30, 2020.

The Contractor shall furnish the product below to: (PLEASE SEE STATEMENT OF WORK)

Ado-Trastuzumab

Azacitidine

Bortezomib

Cabazitaxel

Carboplatin

Carboplatin Etoposide

Carboplatin Fluorouracil

Carboplatin Gemcitabine

Carboplatin Pemetrexed

Carfilizomib

Cisplatin

Cisplatin Docetaxel

Cisplatin Etoposide

Cisplatin Ifosfamide

Cyclophosphamide

Dacarbazine

Docetaxel

Docetaxel Carboplatin

Doxorubacin Vincristine Cyclophosphamide

Doxorubicin

Doxorubicin Bleomycin Dacarbazine

Doxorubicin Bleomycin Vinblastine Dacarbazine

Doxorubicin Cyclophosphamide

Doxorubicin Vincristine Cyclophosphamide

Etoposide

Etoposide Carboplatin Ifosfamide Mesna

Etoposide Cisplatin

Etoposide Vincristine Doxorubicin

Fluorouracil

Gemcitabine Cisplatin

Gemcitabine Docetaxel

Gemcitabine PB Paclitaxel

Irinotecan

Irinotecan Fluorouracil

Liposomal Irinotecan

Methotrexate

Methotrexate Hydrocortisone

Mitomycin

Mitomycin Opth

Oxaliplatin

Oxaliplatin Fluorouracil

Paclitaxel

Paclitaxel Carboplatin

PB Paclitaxel Gemcitabine

Pemetrexed

Pemetrexed Carboplatin

Pertuzumab

Romidepsin

Topotecan

Ado-trastuzumab emtansine

Carfilzomib

Cisplatin Gemcitabine

Cyclophosphamide

Cyclophosphamide Vincristine

Cytarabine

Erlbulin Mesylate

Etoposide Carboplatin Ifosfamide

Etoposide Carboplatin Ifosfamide Mensa

Floxuridine Leucovorin

Fludarabine Cyclophosphamide

Gemcitabine

Gemcitabine Carboplatin

Idarubicin

Irinotecan Carboplatin

P. B. Paclitaxel

P. B. Paclitaxel Gemcitabine

Pentuzumab Carboplatin Docetaxel

Vincristine

Vinorelbine

Vinorelbine Cisplatin

The solicitation will be in accordance with FAR Part 12, 13, and 19, Acquisition of Commercial Items, Simplified Acquisition Procedures, Small Business Programs, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412 size standard 1250 employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award. DUE TO TIME RESTRAINTS, responses to the solicitation shall be due on September 17, 2019 at 12:00 NOON PST. NO EXTRA TIME WILL BE GIVEN. Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments.

Correspondence or questions may be directed to Rosetta Quintons, Contracting Officer at rosetta.quintons@va.gov with 36C26219Q1294 in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired.

Must be registered in System for Award Management upon bid of this request for quote.

Notice: No remanufactures or gray market items/ supplies will not be acceptable. Interested parties of RFI/RFQ must be an authorized reseller, distributor, or dealer of the O.E.M. (Original Equipment Manufacturer). Verification can be provided by an authorization letter or other documents from the OEM. Equipment/Supplies shall be in accordance with the OEM terms and conditions. No exceptions, must be a manufacturer authorized distributor.

Opportunity closing date

17 September 2019

Value of contract

to be confirmed